(Q35132181)

6 August 2017

1 reference

title

Principles of initial experimental drug abuse liability assessment in humans (English)

1 reference

6 August 2017

1 reference

Roland R Griffiths

1

1 reference

PubMed ID

12759196

6 August 2017

George E Bigelow

series ordinal

2

1 reference

PubMed ID

12759196

6 August 2017

Nancy A Ator

series ordinal

3

1 reference

6 August 2017

1 June 2003

1 reference

Drug and Alcohol Dependence

6 August 2017

1 reference

6 August 2017

70

1 reference

6 August 2017

3 Suppl

1 reference

6 August 2017

S41-54

1 reference

Effect of intravenous injection speed on responses to cocaine and hydromorphone in humans

6 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Response patterns of the Spanish version of the 49-item short form of the Addiction Research Center Inventory after the use of sedatives, stimulants, and opioids.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Principles of drug abuse liability assessment in laboratory animals

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Comparative abuse liability of intravenously administered remifentanil and fentanyl.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Human drug abuse liability assessment: opioids and analgesics

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Pharmacologic effects and abuse liability of bretazenil, diazepam, and alprazolam in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Effects of caffeine on cigarette smoking and subjective response.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Preference for ethanol and diazepam in light and moderate social drinkers: a within-subjects study.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Testing the abuse liability of anxiolytic and hypnotic drugs in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Individual differences in the reinforcing and subjective effects of amphetamine and diazepam

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Reinforcing and subjective effects of diazepam in nondrug-abusing volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Abuse liability assessment of anxiolytics/ hypnotics: rationale and laboratory lore

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Preference for diazepam, but not buspirone, in moderate drinkers.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Assessment of abuse liability of stimulant drugs in humans: a methodological survey

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Methods for the assessment of abuse liability of psychomotor stimulants and anorectic agents in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Relative abuse liability of lorazepam and diazepam: an evaluation in 'recreational' drug users

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Physical dependence increases the relative reinforcing effects of caffeine versus placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Benzodiazepine self-administration in humans and laboratory animals--implications for problems of long-term use and abuse.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Comparing the subjective, psychomotor, and physiological effects of intravenous hydromorphone and morphine in healthy volunteers.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Flavor improvement does not increase abuse liability of nicotine chewing gum.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Abuse potential of halazepam and of diazepam in patients recently treated for acute alcohol withdrawal.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Oral caffeine maintenance potentiates the reinforcing and stimulant subjective effects of intravenous nicotine in cigarette smokers

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Abuse liability assessment of neuroprotectants

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Drug-induced mood changes in man. I. Observations on healthy subjects, chronically ill patients, and postaddicts

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Flunitrazepam and triazolam: a comparison of behavioral effects and abuse liability.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Alprazolam absorption kinetics affects abuse liability.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Zaleplon and triazolam in humans: acute behavioral effects and abuse potential

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Acute behavioral and physiological effects of modafinil in drug abusers

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Behavioral pharmacology of abecarnil in baboons

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Caffeine reinforcement: the role of withdrawal

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Nicotine nasal spray and vapor inhaler: abuse liability assessment

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Abuse liability assessment of sibutramine, a novel weight control agent

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Physiological, subjective and reinforcing effects of oral and intravenous cocaine in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

A comparison of the abuse liability and dependence potential of nicotine patch, gum, spray and inhaler.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

Comparative abuse liability of sertraline, alprazolam, and dextroamphetamine in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0376-8716%2803%2900098-X

7 January 2021

10.1016/S0376-8716(03)00098-X

Identifiers

DOI

1 reference

6 August 2017

1 reference

PubMed ID

12759196